Overview

Synaptic Imaging and Network Activity in Treatment Resistant Depression

Status:
Recruiting
Trial end date:
2023-09-11
Target enrollment:
Participant gender:
Summary
The main aim of this research is to explore the effects that ketamine has on the functional connectivity of the brain in participants with treatment resistant depression (TRD). This study will investigate the relationship between these changes and response to treatment as measured by clinical scales, as well as examining drug induced changes in reward and emotion based brain activity, structural connectivity, cerebral blood flow, cognition, metabolism and blood markers of brain plasticity.
Phase:
N/A
Details
Lead Sponsor:
King's College London
Collaborator:
South London and Maudsley NHS Foundation Trust
Treatments:
Ketamine
Midazolam